Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (3) , 475-481
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer RegistriesAnnals of Surgical Oncology, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implicationsRadiotherapy and Oncology, 2010
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body RadiotherapyJournal of Clinical Oncology, 2009
- Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing NationJournal of Clinical Oncology, 2009
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsJournal of Clinical Oncology, 2008
- Dose-individualized stereotactic body radiotherapy for T1–3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapyRadiotherapy and Oncology, 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008